HFA Premium Access

Diverse presentations of transthyretin cardiac amyloidosis beyond heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Miss Anouk Achten

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))
0 follower

6 more presentations in this session

International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction

Speaker: Doctor S. Yun Viladomat (Hospitalet De Llobregat, ES)

Thumbnail

Age- and sex-related trends in transthyretin amyloid cardiomyopathy prevalence in older patients with unexplained hypertrophic cardiomyopathy

Speaker: Professor R. Barriales-Villa (Coruna, A, ES)

Thumbnail

SGLT2 inhibitor treatment in patients with cardiac amyloidosis

Speaker: Doctor D. Lavall (Leipzig, DE)

Thumbnail

Prognostic importance of the 6-minute walk test in transthyretin cardiac amyloidosis

Speaker: Doctor A. Ioannou (Greater London, GB)

Thumbnail

Cardiac manifestations as precursors to ATTR amyloidosis diagnosis: results from the multi-country OverTTuRe study

Speaker: Doctor K. Jarbrink (Gothenburg, SE)

Thumbnail

Access the full session

Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

Speakers: Miss A. Achten, Doctor S. Yun Viladomat, Professor R. Barriales-Villa, Doctor D. Lavall, Doctor A. Ioannou...
Thumbnail

About the event

Image

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations